1 Ocak 2017 Dergi makalesi Açık Erişim

Olah, Zoltan; Redei, Dora; Pecze, Laszlo; Vizler, Csaba; Josvay, Katalin; Forgo, Peter; Winter, Zoltan; Dombi, Gyorgy; Szakonyi, Gerda; Hohmann, Judit

DataCite XML

<?xml version='1.0' encoding='utf-8'?>
<resource xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://datacite.org/schema/kernel-4" xsi:schemaLocation="http://datacite.org/schema/kernel-4 http://schema.datacite.org/meta/kernel-4.1/metadata.xsd">
  <identifier identifierType="URL">https://aperta.ulakbim.gov.tr/record/52089</identifier>
  <creators>
    <creator>
      <creatorName>Olah, Zoltan</creatorName>
      <givenName>Zoltan</givenName>
      <familyName>Olah</familyName>
    </creator>
    <creator>
      <creatorName>Redei, Dora</creatorName>
      <givenName>Dora</givenName>
      <familyName>Redei</familyName>
      <affiliation>Univ Szeged, Dept Pharmacognosy, Szeged, Hungary</affiliation>
    </creator>
    <creator>
      <creatorName>Pecze, Laszlo</creatorName>
      <givenName>Laszlo</givenName>
      <familyName>Pecze</familyName>
    </creator>
    <creator>
      <creatorName>Vizler, Csaba</creatorName>
      <givenName>Csaba</givenName>
      <familyName>Vizler</familyName>
      <affiliation>Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, Szeged, Hungary</affiliation>
    </creator>
    <creator>
      <creatorName>Josvay, Katalin</creatorName>
      <givenName>Katalin</givenName>
      <familyName>Josvay</familyName>
    </creator>
    <creator>
      <creatorName>Forgo, Peter</creatorName>
      <givenName>Peter</givenName>
      <familyName>Forgo</familyName>
    </creator>
    <creator>
      <creatorName>Winter, Zoltan</creatorName>
      <givenName>Zoltan</givenName>
      <familyName>Winter</familyName>
    </creator>
    <creator>
      <creatorName>Dombi, Gyorgy</creatorName>
      <givenName>Gyorgy</givenName>
      <familyName>Dombi</familyName>
      <affiliation>Univ Szeged, Fac Pharm, Inst Pharmaceut Anal, Szeged, Hungary</affiliation>
    </creator>
    <creator>
      <creatorName>Szakonyi, Gerda</creatorName>
      <givenName>Gerda</givenName>
      <familyName>Szakonyi</familyName>
      <affiliation>Univ Szeged, Fac Pharm, Inst Pharmaceut Anal, Szeged, Hungary</affiliation>
    </creator>
    <creator>
      <creatorName>Hohmann, Judit</creatorName>
      <givenName>Judit</givenName>
      <familyName>Hohmann</familyName>
    </creator>
  </creators>
  <titles>
    <title>Pellitorine, An Extract Of Tetradium Daniellii, Is An Antagonist Of The Ion Channel Trpv1</title>
  </titles>
  <publisher>Aperta</publisher>
  <publicationYear>2017</publicationYear>
  <dates>
    <date dateType="Issued">2017-01-01</date>
  </dates>
  <resourceType resourceTypeGeneral="Text">Journal article</resourceType>
  <alternateIdentifiers>
    <alternateIdentifier alternateIdentifierType="url">https://aperta.ulakbim.gov.tr/record/52089</alternateIdentifier>
  </alternateIdentifiers>
  <relatedIdentifiers>
    <relatedIdentifier relatedIdentifierType="DOI" relationType="IsIdenticalTo">10.1016/j.phymed.2017.06.006</relatedIdentifier>
  </relatedIdentifiers>
  <rightsList>
    <rights rightsURI="http://www.opendefinition.org/licenses/cc-by">Creative Commons Attribution</rights>
    <rights rightsURI="info:eu-repo/semantics/openAccess">Open Access</rights>
  </rightsList>
  <descriptions>
    <description descriptionType="Abstract">Background: Transient Receptor Potential Vanilloid 1 (TRPV1) confers noxious heat and inflammatory pain signals in the peripheral nervous system. Clinical trial of resiniferatoxin from Euphorbia species is successfully aimed at TRPV1 in cancer pain management and heading toward new selective painkiller status that further validates this target for drug discovery efforts. Evodia species, used in traditional medicine for hundreds of years, are a recognised source of different TRPV1 agonists, but no antagonist has yet been reported.</description>
  </descriptions>
</resource>